Molina Healthcare, Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; comparisons are with Q1 2023 unless otherwise noted. Molina provides Medicaid, Medicare, and Marketplace managed healthcare services. It served approximately 5.7 million members across 21 states.
Financial performance
| Metric | Q1 2024 | Q1 2023 | Change |
|---|---|---|---|
| Total revenue | $9.931 billion | $8.149 billion | Up 22% |
| Premium revenue | $9.504 billion | $7.885 billion | Up 21% |
| Medical care costs | $8.414 billion | $6.871 billion | Up 22% |
| Medical margin | $1.090 billion | $1.014 billion | Up 7% |
| Operating income | $426 million | $455 million | Down 6% |
| Net income | $301 million | $321 million | Down 6% |
| Diluted EPS | $5.17 | $5.52 | Down 6% |
| Operating cash flow | $214 million | $916 million | Down $702 million |
- Consolidated medical care ratio (MCR) rose to 88.5% from 87.1%; the G&A ratio held at 7.2%. After-tax margin declined to 3.0% from 3.9%.
- Investment income increased to $108 million from $71 million, attributed to higher invested assets and interest rates. Interest expense was $27 million, compared with $28 million.
- By segment, Medicaid revenue was $7.492 billion, medical margin $775 million, and MCR 89.7%; Medicare revenue was $1.442 billion, margin $163 million, and MCR 88.7%; Marketplace revenue was $570 million, margin $152 million, and MCR 73.3%.
Liquidity, cash flow, and debt
- At March 31, cash and cash equivalents were $4.513 billion and investments were $4.424 billion; working capital was $4.2 billion. Cash and investments totaled $9.2 billion, versus $9.4 billion at year-end 2023.
- Cash decreased by $336 million during the quarter. Investing cash outflow was $488 million, including the acquisition-related outflow; financing cash outflow was $62 million. Management attributed lower operating cash flow primarily to timing differences in government receivables and payables and non-risk provider payments.
- Long-term debt was $2.180 billion, with no borrowings on the $1 billion revolving credit facility. The company reported compliance with debt covenants and said it expects liquidity to cover operations, regulatory requirements, debt obligations, and capital expenditures for at least 12 months.
Material changes and developments
- Membership reached 5.727 million, up 9% year over year. Growth reflected new contracts, acquisitions, and existing-market expansion, partly offset by Medicaid redeterminations.
- Bright Health Medicare acquisition closed January 1, adding approximately 109,000 members. The filing describes $441 million in cash paid in MD&A, while the acquisition note reports $427 million of consideration transferred ($341 million cash and $86 million contingent consideration), with a related $14 million receivable. Purchase-price allocation remains provisional.
- New California and Nebraska Medicaid contracts began in January 2024. Molina reported intended Texas and Michigan contract awards and an expected Mississippi contract start between September 2024 and July 2025.
- Florida’s procurement notice did not include Molina as an awardee; Molina is protesting. Virginia upheld its decision not to award Molina a new contract; Molina intends to sue. Virginia extended the existing contract through June 30, 2025, subject to possible earlier termination under the stated terms.
Outlook, risks, and unusual items
- The filing provides no specific numerical full-year earnings or revenue guidance. Management said segment MCRs were in line with expectations overall; Medicaid and Medicare MCRs were slightly above long-term target ranges, while Marketplace MCR was in line with full-year expectations.
- Management estimated approximately 50,000 net Medicaid member losses from redeterminations in Q1 and 550,000 cumulatively; it expects ultimately to retain approximately 40% of membership gained since March 31, 2020. Redeterminations, member acuity, rate adequacy, and medical utilization remain important uncertainties.
- Management attributed lower operating income mainly to expected higher initial MCRs on new contracts, acquisitions, and growth, plus higher G&A expense. Favorable prior-year claims reserve development was $334 million, primarily from lower-than-expected utilization, but its earnings benefit was mostly absorbed by minimum MLRs and medical cost corridors.
- Other operating expenses rose to $38 million from $16 million, reflecting certain non-recurring acquisition costs and litigation costs dating back to 2013. The Texas qui tam case is scheduled for trial in late September 2024; the company says it cannot reasonably estimate the outcome or potential loss. Puerto Rico litigation remains in settlement discussions, with no estimable loss disclosed.
- A February 2024 cybersecurity incident at claims vendor Change Healthcare temporarily impaired some claims and payment processing. Molina reported minimal operational impact and no material financial impact to date, but said it has no specific indication whether member data was breached.
- Interest-rate exposure is material: a hypothetical immediate 1% rate increase would reduce fixed-income investment fair value by approximately $109 million. The company reported $113 million of net unrealized losses on current available-for-sale investments, primarily attributed to interest-rate movements.
Investor facts to verify
- Whether higher MCRs in new and acquired businesses improve as contracts mature, and how Medicaid redeterminations affect membership and acuity.
- Progress and final outcomes of Florida and Virginia procurements, the Virginia contract extension, and expected Texas, Michigan, and Mississippi contract transitions.
- Bright Health Medicare purchase accounting, the difference between the acquisition cash amount and consideration figures reported in the filing, and resolution of the contingent consideration conditions.
- Medical claims reserve development, minimum MLR and corridor liabilities, and the timing-driven decline in operating cash flow.
- Developments in the Texas qui tam and Puerto Rico matters, and any later disclosures about the Change Healthcare incident or potential member-data exposure.